Clinical feature	Statistical test	Significant genes	Associated with	               	Associated with	
Time to Death	Cox regression test	N=3019	shorter survival	N=1360	longer survival	N=1659
AGE	Spearman correlation test	N=3653	older	N=1733	younger	N=1920
PRIMARY SITE OF DISEASE	ANOVA test	N=17317	 	 	 	 
GENDER	t test	N=9010	male	N=4122	female	N=4888
KARNOFSKY PERFORMANCE SCORE	Spearman correlation test	N=206	higher score	N=129	lower score	N=77
HISTOLOGICAL TYPE	ANOVA test	N=16612	 	 	 	 
PATHOLOGY T	Spearman correlation test	N=5976	higher pT	N=3211	lower pT	N=2765
PATHOLOGY N	Spearman correlation test	N=15	higher pN	N=3	lower pN	N=12
PATHOLOGICSPREAD(M)	ANOVA test	N=38	 	 	 	 
TUMOR STAGE	Spearman correlation test	N=7398	higher stage	N=3999	lower stage	N=3399
RADIATIONS RADIATION REGIMENINDICATION	t test	N=5819	yes	N=2864	no	N=2955
NUMBERPACKYEARSSMOKED	Spearman correlation test	N=0	 	 	 	 
STOPPEDSMOKINGYEAR	Spearman correlation test	N=2	higher stoppedsmokingyear	N=0	lower stoppedsmokingyear	N=2
TOBACCOSMOKINGHISTORYINDICATOR	ANOVA test	N=9	 	 	 	 
YEAROFTOBACCOSMOKINGONSET	Spearman correlation test	N=1	higher yearoftobaccosmokingonset	N=0	lower yearoftobaccosmokingonset	N=1
DISTANT METASTASIS	ANOVA test	N=0	 	 	 	 
LYMPH NODE METASTASIS	ANOVA test	N=10	 	 	 	 
COMPLETENESS OF RESECTION	ANOVA test	N=2389	 	 	 	 
NUMBER OF LYMPH NODES	Spearman correlation test	N=0	 	 	 	 
NEOPLASM DISEASESTAGE	ANOVA test	N=19